“…Taking advantage of the data analysis, unique nomenclature, and interlaboratory comparability of MLST, it was possible to gather 367 MLST profiles of C. neoformans and 400 of C. gattii isolates from Latin America, reported in 26 publications [ 20 , 32 , 61 , 66 , 68 , 73 , 75 , 79 , 81 , 84 , 87 , 90 , 91 , 98 , 100 , 106 , 109 , 117 , 123 , 124 , 128 , 138 , 139 , 140 , 141 , 142 ]. MLST studies with clinical and environmental C. neoformans isolates have been reported from Brazil (77.11%), Peru (12.53%), Colombia (9.54), and Argentina (0.82%), while MLST studies with clinical, environmental, and veterinary C. gattii isolates have been reported from Brazil (65.25%), Colombia (26.25%), Mexico (5%), Argentina (1%), Venezuela (1%), and Uruguay (0.75%), as well as Cuba, Guatemala, and Paraguay with one isolate each (0.25%).…”